[Drugs for smoking cessation]
Saeterdal I, Ringerike T, Odgaard-Jensen J, Harboe I, Hagen G, Reikvam A, Klemp M
Record ID 32010001799
English, Norwegian
Authors' recommendations:
Drugs for smoking cessation probably improve smoking cessation after 52 weeks compared with placebo.Varenicline will improve smoking cessation after 52 weeks compared to bupropion.We are uncertain whether there is any difference between different nicotine replacement therapies in terms of achieved smoking cessation.
Combined use of two nicotine replacement products may improve smoking cessation than use of one product.Drugs seem to lead to more side effects than placebo.The documentation is too insufficient for us to determine if the drugs cause serious side effects.
Details
Project Status:
Completed
URL for project:
http://www.kunnskapssenteret.no/Publikasjoner/9188.cms?language=english&threepage=1
Year Published:
2010
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Norway
MeSH Terms
- Humans
- Smoking Cessation
- Smoking Cessation Agents
Contact
Organisation Name:
Norwegian Institute of Public Health
Contact Address:
Universitetsgata 2, Postbox 7004 St. Olavs plass, NO-0310 Oslo NORWAY. Tel: +47 23 25 50 00; Fax: +47 23 25 50 10;
Contact Name:
Berit.Morland@nokc.no, dagny.fredheim@nokc.no
Contact Email:
Berit.Morland@nokc.no, dagny.fredheim@nokc.no
Copyright:
<p>The Norwegian Knowledge Centre for the Health Services</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.